|
Getting your Trinity Audio player ready...
|
Unfortunately, there is a delay in the rollout of the coronavirus vaccine being manufactured by Johnson & Johnson. The vaccine mishap was reported on March 29, 2021.
Fifteen million dosages were polluted when employees at a Baltimore factory mistakenly combined the ingredients of two different coronavirus vaccines. An investigation is currently underway by the Food and Drug Administration and has delayed future delivery to the U.S. This mishap by Johnson & Johnson has prompted them to increase their supervision of Emergent BioSolutions’ performance steer clear of any other quality blunders.
The plant was working on ingredients for the AstraZeneca vaccine as well as the Johnson & Johnson one, but intertwined the two and ruined millions of doses, according to The New York Times.
The facility will now manufacture only one vaccine under the direct order from the Department of Health and Human Services and the Food and Drug Administration.
As of Sunday, April 4, J & J is in charge of the Baltimore plant and the manufacturing of the vaccine. In addition to this change, the facility has been instructed to quit producing the AstraZeneca vaccine. This decision is an attempt to prevent further mistakes.
There is a bright side to this mishap, according to The New York Times report, the mixup did not affect any vaccines presently being distributed or used. Also, despite what has happened, Biden is still anticipating his previously stated target of having a sufficient amount of vaccines for all Americans by the end of May.
Written by Sharri Rogers
Edited by Cathy Milne-Ware
Sources:
The New York Times: Johnson & Johnsons’ vaccine is delayed by a U. S. factory mixup; by Sharon LaFraniere and Noah Weiland
INSIDER: Johnson & Johnson takes over COVID-19 vaccine production at Baltimore plant after 15 million doses were ruined; by John L. Dorman
Images Courtesy of International Monetary Fund’s Flickr Page – Creative Commons License